NHK World-Japan: Developing a new way to fight cancer
International news outlet focuses on the work of Atsuo Sasaki and his cancer research
Atsuo Sasaki, associate professor in the Department of Cancer Biology at the University of Cincinnati and a researcher within the UC Cancer Center, discovered the metabolic mechanism of cells which could open up new possibilities for cancer treatments. A molecule called GTP holds the key.
Sasaki uncovered that a certain enzyme which reacted to GTP in cells acts as an "energy sensor," sending signals for cancer cells to grow. Furthermore, his recent study revealed the mechanism causing nucleolus enlargement in certain cancer cells, a mystery for more than 100 years.
Currently, he is conducting joint research involving scientists at Cincinnati Children's Hospital Medical Center and the UC James L. Winkle College of Pharmacy to uncover how his findings could be connected to metabolic diseases related to obesity.
In addition to Sasaki, Timothy Pheonix, assistant professor at the UC James L. Winkle College of Pharmacy, is featured in this news story. NHK World-Japan is a state-owned international boadcaster aimed at overseas markets and is similar to BBC World News and CNN International.
Watch the full story and learn more about UC research.
Featured photo by Colleen Kelley/UC Creative Services
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.